Pooled Analysis on the Effectiveness and Safety of Lipegfilgrastim in Patients With Urological Malignancies in the Real-World Setting

Lipegfilgrastim is a long-acting glycopegylated granulocyte-colony stimulating factor (G-CSF) approved for the management of chemotherapy-induced neutropenia. In general, there is little information on the use of any G-CSFs specifically in patients with urological malignancies receiving chemotherapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Merseburger, Axel S., Geiges, Götz, Klier, Jörg, Wiesholzer, Martin, Pichler, Petra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8195268/
https://www.ncbi.nlm.nih.gov/pubmed/34123810
http://dx.doi.org/10.3389/fonc.2021.655355

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8195268/
https://www.ncbi.nlm.nih.gov/pubmed/34123810
http://dx.doi.org/10.3389/fonc.2021.655355

Ejemplares similares